MAP 2024 — Molecular Analysis for Precision Oncology Congress 2024

MAP focuses on current and emerging approaches in precision oncology, highlights successes and challenges, and proposes potential solutions in clinical research and practice. This event constitutes an excellent occasion to reunite basic scientists, people working on new technologies, medical doctors, and healthcare providers.

Topics: cancer biology, translational research, molecular pathology, clinical research, immunotherapy, personalised cancer medicine, precision medicine, precision oncology, tumour immunology, anticancer agents, basic science, biological therapy, laboratory medicine, genetic counselling, tumour response evaluation, imaging, molecular imaging, epigenetics, tumours evolution, KRAS, molecular characterisation, clonal evolution, microenvironment in metastasis, myeloid targets for immunotherapy, transcription inhibitors, translation inhibitors, therapeutic targeting, early detection, molecular profiling